NCT02403310 2022-10-03
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
H. Lee Moffitt Cancer Center and Research Institute
Nanfang Hospital, Southern Medical University
Novartis
Applied Spectral Imaging Ltd.
Applied Spectral Imaging Ltd.